https://www.bariatricpal.com/news/medications/peptide-seller-sentenced-misbranded-semaglutide-tirzepatide/ 2026-09-14T17:53:00+00:00 Obesity Treatment News en 2026-09-14T17:53:00+00:00 Michigan man gets 21 months for selling Chinese semaglutide and tirzepatide as research chemicals https://www.bariatricpal.com/news/medications/obesity-medicine-association-2026-cardiovascular-statement/ 2026-09-14T17:31:00+00:00 Obesity Treatment News en 2026-09-14T17:31:00+00:00 Obesity Medicine Association's 2026 heart statement urges treating obesity first, and says it is not a guideline https://www.bariatricpal.com/news/surgery/endoscopic-versus-surgical-bariatric-treatment-ranking/ 2026-09-14T17:14:00+00:00 Obesity Treatment News en 2026-09-14T17:14:00+00:00 Sleeve surgery ranked first among six obesity treatments, on evidence the authors graded very low certainty https://www.bariatricpal.com/news/medications/glp1-suicide-reports-europe-versus-regulator-reviews/ 2026-09-14T17:14:00+00:00 Obesity Treatment News en 2026-09-14T17:14:00+00:00 Suicide-related events made up under 0.3% of 42,941 European GLP-1 safety reports, a count that cannot show cause https://www.bariatricpal.com/news/medications/glp1-drugs-after-bariatric-surgery-pooled-weight-loss/ 2026-09-14T11:20:00+00:00 Obesity Treatment News en 2026-09-14T11:20:00+00:00 GLP-1 drugs after bariatric surgery produced about 9% weight loss at one year, on weak pooled evidence https://www.bariatricpal.com/news/surgery/bariatric-surgery-threshold-population-37-countries/ 2026-09-14T11:20:00+00:00 Obesity Treatment News en 2026-09-14T11:20:00+00:00 Newer bariatric surgery criteria flagged 2.8 times as many adults as the 1991 rules in 37 countries https://www.bariatricpal.com/news/surgery/sleeve-gastrectomy-diabetes-remission-prediction-score/ 2026-09-14T03:11:00+00:00 Obesity Treatment News en 2026-09-14T03:11:00+00:00 Diabetes stayed in remission for 81% of 221 sleeve patients in a Shanghai series, with three tests predicting who https://www.bariatricpal.com/news/medications/adolescent-glp1-mental-health-screening-scores/ 2026-09-14T03:11:00+00:00 Obesity Treatment News en 2026-09-14T03:11:00+00:00 Depression scores fell and suicide screening did not worsen in a 44-teenager GLP-1 chart review https://www.bariatricpal.com/news/surgery/four-bariatric-operations-compared-six-months/ 2026-09-13T23:20:00+00:00 Obesity Treatment News en 2026-09-13T23:20:00+00:00 Gastric bypass beat sleeve on every six-month outcome in a 116,195-patient registry comparison https://www.bariatricpal.com/news/surgery/ssri-weight-loss-after-sleeve-gastrectomy/ 2026-09-13T11:12:00+00:00 Obesity Treatment News en 2026-09-13T11:12:00+00:00 Sleeve patients on SSRIs lost less weight in a 68-person matched study, with depression itself not ruled out https://www.bariatricpal.com/news/medications/glp1-bone-muscle-joint-outcomes-review/ 2026-09-13T11:12:00+00:00 Obesity Treatment News en 2026-09-13T11:12:00+00:00 Large GLP-1 review finds no bone or joint harm, and a lean mass drop the authors call low certainty https://www.bariatricpal.com/news/medications/lilly-mochi-aequita-conspiracy-ruling/ 2026-09-13T00:40:57+00:00 Obesity Treatment News en 2026-09-13T00:40:57+00:00 Judge lets part of Lilly’s Mochi lawsuit proceed, while dismissing an advertising conspiracy theory https://www.bariatricpal.com/news/surgery/one-anastomosis-gastric-bypass-seven-year-outcomes/ 2026-09-12T23:19:00+00:00 Obesity Treatment News en 2026-09-12T23:19:00+00:00 Weight loss largely held at seven years after one-anastomosis gastric bypass in an 80-patient series https://www.bariatricpal.com/news/medications/uk-gp-semaglutide-heart-risk-funding-confirmation/ 2026-09-12T23:19:00+00:00 Obesity Treatment News en 2026-09-12T23:19:00+00:00 UK doctors' union tells GPs not to start Wegovy for heart risk without written proof of funding https://www.bariatricpal.com/news/surgery/perioperative-heart-events-after-bariatric-surgery/ 2026-09-12T11:13:48+00:00 https://www.bariatricpal.com/news/surgery/endoscopic-sleeve-versus-sleeve-gastrectomy-long-term/ 2026-09-12T10:48:00+00:00 https://www.bariatricpal.com/news/medications/tirzepatide-atrial-fibrillation-arrhythmia-meta-analysis/ 2026-09-12T10:48:00+00:00 https://www.bariatricpal.com/news/surgery/alcohol-absorption-after-one-anastomosis-gastric-bypass/ 2026-09-12T10:48:00+00:00 https://www.bariatricpal.com/news/surgery/australia-public-private-bariatric-follow-up/ 2026-09-09T11:09:37+00:00 https://www.bariatricpal.com/news/medications/structure-aleniglipron-oral-amylin-trial-results/ 2026-09-08T23:47:38+00:00 https://www.bariatricpal.com/news/medications/step-young-semaglutide-childhood-obesity-topline/ 2026-09-08T11:04:37+00:00 https://www.bariatricpal.com/news/medications/glp1-knee-replacement-joint-infection-risk/ 2026-09-07T23:16:00+00:00 https://www.bariatricpal.com/news/surgery/adolescent-bariatric-surgery-hospital-volume-outcomes/ 2026-09-07T23:16:00+00:00 https://www.bariatricpal.com/news/surgery/surgery-versus-glp1-heart-outcomes-analysis/ 2026-09-07T21:41:27+00:00 https://www.bariatricpal.com/news/surgery/sleeve-gastrectomy-pcos-weight-loss-trajectories/ 2026-09-07T21:41:27+00:00 https://www.bariatricpal.com/news/surgery/sadi-s-safety-surgeon-learning-curve-michigan/ 2026-09-07T21:41:27+00:00 https://www.bariatricpal.com/news/surgery/post-bariatric-hypoglycemia-care-gap-survey/ 2026-09-05T17:17:00+00:00 https://www.bariatricpal.com/news/surgery/adolescent-bariatric-surgery-use-2016-2025/ 2026-09-07T21:41:27+00:00 https://www.bariatricpal.com/news/surgery/supervised-exercise-after-bariatric-surgery-trial/ 2026-09-07T21:41:27+00:00 https://www.bariatricpal.com/news/medications/glp1-naion-optic-nerve-vision-loss-cohort/ 2026-09-07T21:41:27+00:00 https://www.bariatricpal.com/news/surgery/robotic-gastric-bypass-readmissions-serious-complications/ 2026-09-04T23:14:00+00:00 https://www.bariatricpal.com/news/medications/opioid-choice-gut-risk-glp1-patients/ 2026-09-07T21:41:27+00:00 https://www.bariatricpal.com/news/medications/glp1-prescribing-children-ages-8-to-11/ 2026-09-04T11:24:00+00:00 https://www.bariatricpal.com/news/medications/semaglutide-lifespan-female-mice-late-life/ 2026-09-03T23:19:00+00:00 https://www.bariatricpal.com/news/medications/fda-warning-letters-research-peptide-sellers/ 2026-09-03T23:19:00+00:00 https://www.bariatricpal.com/news/medications/weight-regain-after-stopping-semaglutide-tirzepatide/ 2026-09-03T17:13:00+00:00 https://www.bariatricpal.com/news/surgery/excess-weight-metrics-misrepresent-surgery-results/ 2026-09-07T21:41:27+00:00 https://www.bariatricpal.com/news/surgery/robotic-duodenal-switch-readmission-registry/ 2026-09-07T21:41:27+00:00 https://www.bariatricpal.com/news/surgery/ten-year-weight-trajectory-uk-bariatric-patients/ 2026-09-03T11:39:00+00:00 https://www.bariatricpal.com/news/medications/sleeve-versus-semaglutide-liver-markers/ 2026-09-03T11:39:00+00:00 https://www.bariatricpal.com/news/medications/glp1-weight-loss-evidence-updated-review/ 2026-09-03T11:39:00+00:00 https://www.bariatricpal.com/news/medications/lipofit-fat-burner-recall-dnp-fluoxetine/ 2026-09-02T22:14:00+00:00 https://www.bariatricpal.com/news/surgery/pregnancy-surgical-emergencies-after-bariatric-surgery/ 2026-09-02T22:14:00+00:00 https://www.bariatricpal.com/news/surgery/endoscopic-sleeve-versus-oral-semaglutide/ 2026-09-02T22:14:00+00:00 https://www.bariatricpal.com/news/surgery/extreme-obesity-bmi-60-surgery-outcomes/ 2026-09-07T21:41:27+00:00 https://www.bariatricpal.com/news/medications/california-sb-1089-glp1-calrx-enrolled/ 2026-09-02T05:05:49+00:00 https://www.bariatricpal.com/news/medications/fifth-circuit-compounded-glp1-shortage-rulings/ 2026-09-02T05:04:49+00:00 https://www.bariatricpal.com/news/medications/zepbound-healthcare-cost-trends-older-adults/ 2026-08-31T19:09:56+00:00 https://www.bariatricpal.com/news/medications/mounjaro-fda-cardiovascular-risk-indication/ 2026-08-31T13:50:07+00:00 https://www.bariatricpal.com/news/medications/medicare-discount-exclusions/ 2026-08-31T13:18:36+00:00